Wells Fargo’s Mural Oncology MURA Stock Holding History

Wells Fargo’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,171	Closed	-$2.42K	–	7280
2025 Q3	$2.42K	Sell	1,171 -132	-10%	-$284	﹤0.01%	6159
2025 Q2	$3.22K	Sell	1,303 -140	-10%	-$330	﹤0.01%	6145
2025 Q1	$1.82K	Buy	1,443 +898	+165%	+$3.27K	﹤0.01%	6169
2024 Q4	$1.75K	Sell	545 -5	-0.9%	-$18	﹤0.01%	6204
2024 Q3	$1.72K	Sell	550 -9	-2%	-$29	﹤0.01%	6068
2024 Q2	$1.76K	Sell	559 -5,042	-90%	-$18.6K	﹤0.01%	6036
2024 Q1	$27.4K	Sell	5,601 -143	-2%	-$694	﹤0.01%	5478
2023 Q4	$34K	Buy	+5,744	New	+$23.1K	﹤0.01%	5417

Wells Fargo's MURA Position: Q4 2025 in Review

Wells Fargo sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 1,171 shares — an estimated $2.42K sold.

Wells Fargo first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $34K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Wells Fargo reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Wells Fargo sold 1,171 Mural Oncology shares in Q4 2025, an estimated $2.42K.
Wells Fargo first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Wells Fargo's Mural Oncology position peaked at $34K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.